Evidence map›Paper›PMID 41792450›Full record

ArticleThe Journal of antibiotics2026

Combination of combined-culture of Amycolatopsis sp. with Tsukamurella pulmonis and GNPS molecular networking reveals novel sulfur-containing cyclic lipopeptides thioamycolamides F-I.

Chengqian Pan, Lei Zhang, Takefumi Kuranaga, Hiroyasu Onaka, Naoya Shinzato, Hideaki Kakeya

Abstract read
PubMed Publisher
In one paragraph

Article in The Journal of antibiotics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chengqian PanSchool of Pharmacy, Jiangsu University, Zhenjiang, China.
Lei ZhangDepartment of System Chemotherapy and Molecular Sciences, Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Takefumi KuranagaDepartment of System Chemotherapy and Molecular Sciences, Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
Hiroyasu OnakaDepartment of Life Science, Faculty of Science, Gakushuin University, Toshima, Tokyo, Japan.ORCID http://orcid.org/0000-0003-4536-1881
Naoya ShinzatoTropical Biosphere Research Center, University of the Ryukyus, Okinawa, Japan.
Hideaki KakeyaDepartment of System Chemotherapy and Molecular Sciences, Division of Medicinal Frontier Sciences, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan. scseigyo-hisyo@pharm.kyoto-u.ac.jp.ORCID http://orcid.org/0000-0002-4293-7331

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of novel sulfur-containing cyclic lipopeptides named thioamycolamides F-I (1-4), with thiazoline, sulfoxide/sulfide, and fatty acid moieties, was discovered by applying GNPS molecular networking technology against combined-culture broth of Amycolatopsis sp. 26-4 and Tsukamurella pulmonis TP-B0596. Planar structural elucidation was accomplished by HRMS and 1D/2D NMR spectroscopic data analyses. The absolute configuration was determined by the highly sensitive advanced Marfey's method developed by our group, electronic circular dichroism (ECD) spectroscopy, chemical synthesis, and Gaussian calculation. Moreover, compound 2 exhibited cytotoxicity against human cervix adenocarcinoma HeLa S3 cells with an IC

Indexed as

AmycolatopsisAnti-Bacterial AgentsLipopeptidesPeptides, CyclicAntineoplastic AgentsCircular DichroismHeLa CellsHumansInhibitory Concentration 50Magnetic Resonance SpectroscopySulfurAnti-Bacterial AgentsAntineoplastic AgentsLipopeptidesPeptides, CyclicSulfur

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.